Indian equity markets are dealing with a broad decline as investors react to rising bond yields and potential RBI rate hike concerns. While the Nifty 50 tests key support levels, analysts are pointing to a selective market where technology and infrastructure stocks show different technical patterns compared to the weakness seen in segments like healthcare.
The Indian stock market began the week under pressure, with the Nifty 50 facing persistent selling as it approaches key support zones between 22,000 and 22,200. This weakness is largely driven by a combination of rising bond yields and growing caution ahead of the upcoming Reserve Bank of India (RBI) policy meeting. With inflation concerns persisting, the market is bracing for potential interest rate adjustments, leading to a shift in how investors approach their portfolios.
Market experts are describing this phase as a stock-picker's market, where broader index trends offer little comfort, forcing participants to focus on individual stock technicals rather than broad sector rallies. This shift means that even while the overall market is down, some stocks are showing distinct patterns of strength, while others remain under heavy selling pressure.
In the technology space, Infosys has caught the eye of some technical analysts. The stock has shown signs of a potential short-term reversal, with indicators like double-bottom patterns and bullish divergence appearing near the ₹1,000 level. This suggests some renewed buying interest, although the sustainability of this move will depend on whether the stock can maintain its momentum against broader market volatility.
Infrastructure stocks are also seeing varied action. JSW Infrastructure is currently testing breakout patterns above ₹340, a level that analysts are monitoring for further clues. Similarly, Schneider Electric Infrastructure has demonstrated strong momentum, with the stock trading near ₹1,275. While these movements have drawn attention, investors are also weighing valuation risks. Companies in this space that have seen a steep run-up are now trading at high price-to-earnings ratios, making them sensitive to any sharp market corrections.
On the other side of the ledger, the healthcare sector is showing clear signs of weakness. Sun Pharmaceutical Industries has been flagged for a bearish outlook, with the stock consistently trading below its 200-day moving average. Technical analysts monitoring this stock are keeping an eye on support levels around ₹1,775 to ₹1,800. A breach of these levels could signal further selling pressure, as the stock struggles to find consistent demand.
The broader outlook remains cautious. With rising US and domestic bond yields adding pressure, the market is vulnerable to consolidation. If the Nifty 50 fails to hold its current support, it may trigger more broad-based selling. Investors will likely look to the RBI policy outcome this week as the primary trigger for the next direction in market sentiment, while maintaining strict observation of key support levels for their holdings.